bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Fennec Pharmaceuticals Inc. logo

    Fennec Pharmaceuticals Inc.

    FENC | NASDAQ
    Chart Builder DCF Calculator
    $10.91
    +$0.29 (+2.73%)
    At close: Sep 21, 2026, 4:00 PM ET
    $10.91
    $0 (0.00%)
    After-hours: Sep 21, 2026, 7:30 PM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $378.98M
    Enterprise Value
    $337.73M
    Beta
    1.10
    Average Volume
    263.72K
    Shares Outstanding (Diluted)
    36.43M
    Shares Change YoY
    31.69%
    Institutional Ownership
    47.18%
    Exchange
    NASDAQ
    ISIN
    CA31447P1009

    Price Performance

    Price Change 1M
    -3.0%
    Price Change 3M
    5.9%
    Price Change 6M
    76.8%
    Price Change YTD
    42.1%
    Price Change 1Y
    25.8%
    Price Change 3Y
    45.7%
    Price Change 5Y
    16.2%
    1M CAGR (ann.)
    -5.8%
    1Y CAGR (ann.)
    22.2%
    5Y CAGR (ann.)
    4.7%
    All-Time CAGR
    -1.1%

    Valuation

    PE Ratio
    -77.93
    Forward PE
    12.43
    PEG Ratio
    -1.50
    Forward PEG
    -0.36
    PS Ratio
    6.40
    Forward PS
    3.70
    PB Ratio
    8.93
    P/FCF Ratio
    -185.77
    P/Adj. FCF Ratio
    -44.30
    P/OCF Ratio
    -181.83
    EV/Sales
    5.70
    EV/EBIT
    -136.18
    EV/EBITDA
    -142.14
    EV/FCF
    -165.55
    Earnings Yield
    -1.3%
    FCF Yield
    -0.5%
    Adj. FCF Yield
    -2.3%

    Financial Health

    Net Cash
    $41.25M
    Total Debt
    $0
    Cash & Short-Term Investments
    $41.25M
    Total Assets
    $75.75M
    Current Ratio
    5.85
    Quick Ratio
    5.66
    Debt / Equity Ratio
    0.00
    Debt / EBITDA
    -0.00
    Debt / FCF
    -0.00
    OCF / Debt
    N/A
    Interest Coverage
    -1.29
    Altman Z-Score
    4.25
    Piotroski F-Score
    6

    Margins & Profitability

    Gross Profit Margin
    93.7%
    Operating Profit Margin
    -2.0%
    EBITDA Margin
    -4.0%
    Net Profit Margin
    -5.5%
    FCF Margin
    -3.4%
    Adj. FCF Margin
    -14.4%
    SBC / Revenue
    11.0%
    SBC Impact (per share)
    -319.4%

    Returns

    Return on Assets
    -4.3%
    Return on Equity
    -11.7%
    Return on Invested Capital
    -1.8%
    Return on Capital Employed
    -1.8%
    Return on Tangible Assets
    -4.3%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    108.5%
    Revenue CAGR 5Y
    222.4%
    Revenue CAGR 10Y
    42.1%
    EPS CAGR 3Y
    -50.9%
    EPS CAGR 5Y
    37.7%
    EPS CAGR 10Y
    5.1%
    FCF CAGR 3Y
    -403.8%
    FCF CAGR 5Y
    62.3%
    FCF CAGR 10Y
    8.5%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    8
    EPS Growth Next 3Y
    743.6%
    Revenue Growth Next 3Y
    48.5%
    Earnings Date
    Nov 11, 2026
    EPS Estimate (next Q)
    $0.09
    EPS Growth Est (next Q)
    -550.0%
    Revenue Est (next Q)
    $18.91M
    Revenue Growth Est (next Q)
    51.7%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $16
    Price Target Upside
    46.7%

    Cash Flow

    Operating Cash Flow
    $-2.04M
    Free Cash Flow
    $-2.04M
    Adj. Free Cash Flow
    $-8.56M
    FCF Per Share
    -$0.06
    OCF Per Share
    -$0.06
    OCF/S Ratio
    -3.4%

    Income Statement

    Revenue
    $59.22M
    Gross Profit
    $55.51M
    Operating Income
    $-1.16M
    EBITDA
    $-2.38M
    Net Income
    $-3.25M
    EPS (Diluted)
    -$0.14
    Revenue / Employee
    $1.69M
    Profit / Employee
    $-92.89K
    Employees
    35

    © 2026 bestshares.com. All rights reserved.